The Value Initiative is the Society of Nuclear Medicine and Molecular Imaging’s strategic vision and roadmap for working with industry and other partners to advance the crucial role of nuclear medicine, molecular imaging, and radiopharmaceutical therapy to the medical community, regulators, patients, and the public. 

Value Initiative In Action

CEO Summit and Panel Discussion: 
The Potential, Promise, and Value of Radiopharmaceutical Therapy

Watch this engaging discussion from the SNMMI 2021 Annual Meeting on system-wide ways to improve patient access and clinical outcomes, including what lessons can be learned from the past to ensure new therapies get from bench to bedside more effectively.
Meet the Panelists | Value Stream Mapping | Get Involved.

Value Initiative: Winter Update 2021

2021 Begins with Exciting Progress
The launch of the dedicated Radiopharmaceutical Therapy Central website, Dosimetry Challenge, and positive news on Coverage of Non-Oncologic PET highlight early 2021 efforts.

March 2021 Presentation  | 2021 Winter Updates


Learn more about our Value Initiative Industry Alliance Member Companies.

Leadership Circle            


Visionary Member      

Principal Member                   


Corporate Member